0001144204-16-110884.txt : 20160630 0001144204-16-110884.hdr.sgml : 20160630 20160630171139 ACCESSION NUMBER: 0001144204-16-110884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160629 FILED AS OF DATE: 20160630 DATE AS OF CHANGE: 20160630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 BUSINESS ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Mark S CENTRAL INDEX KEY: 0001622779 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 161743871 MAIL ADDRESS: STREET 1: C/O CELSUS THERAPEUTICS PLC STREET 2: 24 WEST 40TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 4 1 v443329_4.xml OWNERSHIP DOCUMENT X0306 4 2016-06-29 0 0001541157 Akari Therapeutics Plc AKTX 0001622779 Cohen Mark S C/O AKARI THERAPEUTICS PLC 24 WEST 40TH STREET, 8TH FLOOR NEW YORK NY 10018 1 0 0 0 Options to Purchase Ordinary Shares 0.1454 2016-06-29 4 A 0 1300000 0 A 2026-06-29 Ordinary Shares 1300000 1300000 D All shares underlying the options will vest in full on the date of the Issuer's 2017 Annual General Meeting and expire ten years from issuance. /s/ Dov Elefant, as attorney-in-fact 2016-06-30